Showing results (641-650 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|May 19, 2006
FXR: a target for cholestatic syndromes?Shi-Ying Cai, James L BoyerExpert Opinion on Therapeutic Targets|May 19, 2006
Targeting glycogen synthase kinase-3 in insulin signallingSheelagh Frame, Daniella ZhelevaExpert Opinion on Therapeutic Targets|September 3, 2021
Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristicsHaichuan Wang, Xin Chen, Diego F CalvisiExpert Opinion on Therapeutic Targets|May 10, 2015
Angiogenesis in salivary gland tumors: from clinical significance to treatmentStamatios Theocharis, George Gribilas, Constantinos Giaginis, et al.Expert Opinion on Therapeutic Targets|May 16, 2015
Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapyHelena Pópulo, Regina Caldas, José Manuel Lopes, et al.Expert Opinion on Therapeutic Targets|April 28, 2020
Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitabilityPhan Q Duy, Miao He, Zhigang He, et al.Expert Opinion on Therapeutic Targets|May 13, 2020
Glioblastoma multiforme: novel therapeutic targetsMatthew Muir, Sricharan Gopakumar, Jeffrey Traylor, et al.Expert Opinion on Therapeutic Targets|October 23, 2019
Fluoxetine induces glucose uptake and modifies glucose transporter palmitoylation in human peripheral blood mononuclear cellsBritta Stapel, Nataliya Gorinski, Noëmi Gmahl, et al.Expert Opinion on Therapeutic Targets|August 23, 2021
The CB2 cannabinoid receptor as a therapeutic target in the central nervous systemDavid Cabañero, Elena Martín-García, Rafael MaldonadoExpert Opinion on Therapeutic Targets|December 9, 2004
Emerging technologies for the identification of therapeutic targets for the management of pre-eclampsiaD C Pritlove, B K Tan, N C J de Wit, et al.Pageof 232